Risk Factors for Colonization With Multidrug-Resistant Bacteria Among Patients Admitted to the Intensive Care Unit

Marion Angue1, Nicolas Allou1, Olivier Belmonte2

  • 1Intensive Care Unit, CHU Félix Guyon, Saint-Denis, France.

Abstract

Insights

Patients returning from abroad, especially those hospitalized and treated with antibiotics, have a higher risk of carrying multidrug-resistant (MDR) bacteria. Screening these travelers is recommended to prevent ICU infections.

Area of Science:

  • Infectious Diseases
  • Intensive Care Medicine
  • Microbiology

Background:

  • Limited national guidelines exist for managing patients returning from abroad, particularly for non-hospitalized individuals.
  • Focus has been on hospitalized patients, leaving a gap in understanding risks for those admitted to intensive care units (ICUs).

Purpose of the Study:

  • To compare the prevalence and acquisition of multidrug-resistant (MDR) bacteria carriage in ICU patients with recent stays abroad versus local patients.
  • To identify specific risk factors for MDR bacteria carriage among patients with a history of travel abroad.

Main Methods:

  • Retrospective chart review of 1,842 ICU patients from January 2011 to July 2013.
  • Identification of patients with stays abroad within six months prior to ICU admission.
  • Analysis of hygiene sampling data to determine MDR bacteria carriage and acquisition rates.

Main Results:

  • 7% of ICU patients (129/1,842) had stayed abroad.
  • The 'Abroad' group showed significantly higher MDR bacteria carriage at admission (33% vs. 6.7%) and acquisition during ICU stay (17% vs. 5.2%) compared to 'Local' patients.
  • Key risk factors for MDR carriage in 'Abroad' patients included diabetes mellitus (OR 5.1) and hospitalization abroad with antibiotic treatment (OR 10.7).

Conclusions:

  • Hospitalization abroad, particularly with antibiotic treatment, is a significant risk factor for MDR bacteria carriage in ICU patients.
  • Screening and isolation of patients returning from abroad are recommended, even with initial negative screenings.
  • This highlights the importance of considering travel history in infection control protocols for ICU patients.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
52
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
6.7K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.7K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
132
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
47
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K